Cybin Inc (NYSE: CYBN), a Toronto-based biotechnology company focused on utilizing psychedelic drugs as an alternative to traditional psychiatric drugs, announced positive pre-clinical data, indicating that its drug, CYB003 showed strong signs of cognitive improvement in patients with Major Depressive Disorder
Avalon Holdings Corporation Common Stock (AMEX:AWX) reported quarterly earnings of $0.25 per share. This is a 25 percent increase over earnings of $0.20 per share from the same period last year. The company reported
LivePerson, Inc. (Nasdaq: LPSN), a global leader in Conversational AI, and Communication Business Avenue (CBA), which develops solutions for contact centers and various business automation tools and solutions, today announced a partnership to jointly scale LivePerson's Conversational Cloud into new territories and accounts.